Back to BAKER BROS. ADVISORS LP

KYMR
Showing 8 of 23 quarters

Position history for BAKER BROS. ADVISORS LP's holdings in KYMERA THERAPEUTICS INC

BAKER BROS. ADVISORS LP holds 8.7M shares of KYMR (KYMERA THERAPEUTICS INC), worth $721.1M as of 2026-Q1. KYMR represents 4.1% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$721.1M

Current Shares

8.7M

Total Value Change

+$542.1M

Total Shares Change

+2.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
8.7M
0.0%
$721.1M4.1%$86.35
0
2025-Q4
Increased
8.7M
+30.2%
$673.6M3.9%$78.12
73
2025-Q3
Unchanged
6.7M
0.0%
$376.5M2.7%$58.50
0
2025-Q2
Increased
6.7M
+10.9%
$290.3M2.8%$44.12
59
2025-Q1
Unchanged
6M
0.0%
$164.1M1.8%$29.62
0
2024-Q4
Unchanged
6M
0.0%
$241.2M2.6%$39.32
0
2024-Q3
Increased
6M
0.0%
$283.8M2.9%$48.69
53
2024-Q2
Unchanged
6M
0.0%
$179M2.3%$29.85
0

Other major holders of KYMR: FMR LLC, Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used